Dr Penny Attridge

Penny is an Investment Director at SPARK Impact Ltd. SPARK manage the NorthWest Fund for Biomedical which is a £25m Fund and the office is based at Liverpool Science Park. Prior to SPARK, Penny joined Quester in 2005 and prior to that was with BTG plc working in client development, identifying and acquiring early stage inventions from academia and SMEs in the UK, which were then developed and commercialised by BTG. She also spent many years with the Public Health Laboratory Service, and had a notable academic career with over 100 previewed publications in the field of applied medical microbiology.

In addition, Penny is a Founder and Director of Id-Tech Ltd., a company that has successfully exploited her inventions to prevent needlestick injuries.